Early rises in oxygen use inside new MS brain lesions are linked to healing of the protective myelin layer, suggesting a new MRI sign of repair.
Researchers followed 22 people with MS who had new active brain lesions and scanned them at the start, 3 months, and 12 months. They measured how much oxygen the tissue was using (OEF) and how much myelin was present (MWF, a measure of the protective coating on nerve fibers). Both oxygen use and myelin amount rose from the start to 3 months, then stayed about the same from 3 to 12 months. The increase in oxygen use and the increase in myelin were linked — lesions that showed bigger oxygen increases also showed more myelin recovery. The authors think the early oxygen rise reflects the energy needs of cells that rebuild myelin, so that oxygen signal could be a clue that repair is happening.
People with MS who want to know whether their brain lesions are healing may benefit, because this finding points to a noninvasive clue doctors could watch on MRI. Caregivers may find it reassuring to learn that the brain can show signs of repair after a new lesion, not only damage. Neurologists and MS specialists could use oxygen-measure MRI methods to track remyelination when testing treatments that aim to repair myelin. Think of it like watching smoke (oxygen use) rise where a house fire was — seeing smoke go up early could mean firefighters (repair cells) are active. This could change follow-up plans by giving doctors another way to tell if a lesion is recovering over the first few months.
The study had a small sample (22 patients and 68 lesions), so findings need confirmation in larger groups before changing care. The MRI methods used are specialized and not yet common in routine clinical scans, so this clue may not be available everywhere. An increase in oxygen use likely means repair activity, but it might also reflect other processes, so doctors will need multiple types of information before concluding healing is happening.
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More5/1/2026
Study finds CD29 marks blood B cells that can enter the brain and become antibody-producing cells in
Read More5/1/2026
Study finds early detection, lower spinal fluid virus, and PML‑IRIS relate to better 1‑year outcomes
Read More5/1/2026
Study found fewer hospital diagnoses of antibody-positive autoimmune encephalitis during COVID-19, b
Read More3/1/2026
Study shows C5 inhibitors given during or soon after NMOSD attacks helped most patients stabilize or
Read More3/1/2026
Early OCT eye scans can often distinguish MOGAD from NMOSD optic neuritis, helping guide faster trea
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.